𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human papillomavirus infection and P53 codon 72 genotypes in a hispanic population at high-risk for cervical cancer

✍ Scribed by Andrea L. Fuessel Haws; Sabine Woeber; Miroslava Gomez; Noe Garza; Yvonne Gomez; Peter Rady; Qin He; Lifang Zhang; James J. Grady; Joseph B. McCormick; Susan P. Fisher-Hoch; Stephen K. Tyring


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
118 KB
Volume
77
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Cervical cancer mortality is high in Texas, especially among Hispanic women living in south Texas and adjacent Mexico. Though human papillomavirus (HPV) infection has a causal role in the development of cervical cancer, there are no published data on the prevalence of HPV genotypes in this underscreened region. We studied 398 Hispanic women on both sides of the border along the lower Rio Grande River to determine the prevalence of HPV genotypes and risk factors for cervical cancer. Using a nested PCR system HPV was detected in 62% of cervical specimens, including all the known high-risk HPV genotypes, with HPV16 and HPV18 the most frequent (30.6% and 23.0%, respectively). Multiple infections were common (29.4% of the infected specimens), and where this occurred we were more likely to find high-risk HPV genotypes. We examined host p53 codon 72 genotype frequencies and found that patients with cervical abnormalities and women with HPV16 and HPV18 infections had a lower genotype frequency of the homozygous (AA) previously reported to be associated with cervical cancer, than uninfected women with no abnormalities. In this US/Mexico border population high rates of potentially oncogenic HPV viruses and multiple infections are consistent with observed elevated cervical cancer rates. These data are further evidence that in this underserved population HPV infections are associated with high rates of malignancy, but that host p53 genotypic variations are unlikely to be primary factors in oncogenesis.


📜 SIMILAR VOLUMES


HPV-based cervical cancer screening in a
✍ Sharita D. Womack; Z. Michael Chirenje; Lynne Gaffikin; Paul D. Blumenthal; John 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 61 KB 👁 2 views

We determined the utility of an assay for 13 cancerassociated HPV types in primary cervical cancer screening of Zimbabwe women at high risk of HIV infection. HIV antibody status was determined by ELISA of oral mucosal specimens, and HPV DNA in the genital tract was identified by hybridization of cer

Natural history and screening model for
✍ Johannes Berkhof; Martine C de Bruijne; Gilda D Zielinski; Chris JLM Meijer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 126 KB 👁 2 views

## Abstract A simulation model is presented that assumes that persistent infection with high‐risk human papillomavirus (hrHPV) is a necessary cause of cervical cancer. For the estimation of the model parameters, data of recent Dutch follow‐up studies were reanalyzed. The predicted incidences of cer

High-risk human papillomavirus DNA load
✍ Albertus T. Hesselink; Johannes Berkhof; Daniëlle A.M. Heideman; Nicole W.J. Bul 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 137 KB 👁 2 views

## Abstract In a population‐based cervical screening cohort, we determined the value of type‐specific viral load assessment for the detection of high‐grade cervical intraepithelial neoplasia and cervical cancer (≥CIN2). Viral load was determined by type‐specific real‐time PCR in women with single H

Recurrent human papillomavirus infection
✍ Jean-Paul Bory; Joël Cucherousset; Marianne Lorenzato; René Gabriel; Christian Q 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 75 KB 👁 1 views

## Abstract To test the reliability of the Hybrid Capture II (HC‐II) assay detecting 13 high‐risk human papillomavirus (HR‐HPV) types for the screening of cervical lesions, we monitored by cytology, HR‐HPV testing, colposcopy and biopsy, 3,091 women with normal smears at the first entry. Our primar